24/7 Customer Support
Global Dermatology Drugs Market was valued at US$ 18.42 billion in 2022 and is estimated to reach a valuation of US$ 45.35 billion and 79.24 metric ton in terms of volume by 2031. The market is anticipated to grow at a CAGR of 11.0% during the forecast period 2023-2031.
Growing awareness of skin diseases, increasing demand for innovative drugs, and also growing investment in R&D for developing new drugs are some of the important factors driving are growth of the global dermatology drugs market. The most common skin diseases are acne, eczema, psoriasis, and skin cancer. These diseases are caused by a variety of factors such as genetics, lifestyle, environmental factors, and infections. The prevalence of these diseases is increasing due to the changing lifestyle and environmental factors. The treatment of skin diseases requires various topical and systemic agents.
The most commonly used topical agents are corticosteroids, retinoids, antifungals, antibiotics, and antihistamines. Systemic agents include immunosuppressants, biologics, and small-molecule therapeutics. The choice of treatment depends on the type and severity of the disease. The increase in the incidence of skin diseases is the major factor driving the growth of the dermatology drugs market. The rising awareness about the importance of skin health and the availability of effective treatments are also fueling the growth of this market.
To Get more Insights, Request A Free Sample
By drug type, the global dermatology drugs market is classified into branded prescription drugs, generic prescription drugs, and over-the counter drugs (OTC). Under drug type, branded prescription drugs held the highest share of 53.9% in 2022 while over-the counter drugs (OTC) are growing at the highest CAGR of 12.0%.
The majority of dermatology drugs are used to treat conditions such as acne, eczema, psoriasis, and skin infections. These drugs are available in a variety of formulations including creams, gels, lotions, ointments, and solutions. Some are designed for specific body areas such as the face or scalp while others can be used on any part of the body. The most common active ingredients in dermatology drugs market are corticosteroids, retinoids, antibiotics, antifungals, and keratolytic agents. Corticosteroids are used to reduce inflammation while retinoids help to unplug blocked pores and reduce cell turnover. Antibiotics are used to kill bacteria that cause infections while antifungals are used to treat fungal infections. Keratolytic agents help to break down buildup on the skin's surface.
Based on formulation, the dermatology drugs market is further classified into ointments, cream, lotion, gel, tablets, and other formulations. This is due to the rising prevalence of skin diseases such as eczema, psoriasis, acne, cold sore, hives, eczema, and others. Atopic dermatitis patients between the ages of 12 and 18 have the highest incidence rate of acne, especially among women.
Based on route of administration, the global dermatology drugs market is classified into oral medicines, topical medicines, and parenteral medicines. Topical drugs are holding the largest market share.
The most common types of topical dermatologic drugs are corticosteroids, antifungals, antibiotics, and retinoids. Topical corticosteroids are the most commonly used type of topical dermatologic drug. They are effective in treating a wide variety of inflammatory skin conditions, such as eczema, psoriasis, and allergic contact dermatitis. Topical corticosteroids can be divided into two groups: first-generation and second-generation. First-generation topical corticosteroids are more potent and have more side effects than second-generation drugs. Second-generation drugs in the global dermatology drugs market are generally preferred over first-generation drugs because they are more effective with fewer side effects. Antifungal medications are used to treat fungal infections of the skin, such as athlete's foot, jock itch, and ringworm. Antibiotic medications are used to treat bacterial infections of the skin, such as acne and cellulitis. Retinoids are vitamin A derivatives that are used to treat a variety of conditions, including acne, photoaging, and psoriasis.
To Understand More About this Research: Request A Free Sample
Based on the therapeutic application, the dermatology drugs market is bifurcated into acne, dermatitis, psoriasis, rosacea, inflammatory dermatoses, and others. Most common application is acne and dermatitis.
The analysis of acne treatment and prevalence found that the majority of acne sufferers across the globe are treated with topical medication, while a smaller number use oral medication. The most common topical medications used to treat acne are benzoyl peroxide and salicylic acid, while the most commonly prescribed oral medications are tetracyclines. The analysis of the global dermatology drugs market also found that the prevalence of acne is highest among teenagers and young adults, with nearly 80% of sufferers being between the ages of 12 and 24. Acne is also more common among women than men, with nearly 60% of sufferers
Based on distribution channel, the global dermatology drugs market is classified into retail channel, non-retail, and online channel. The online channel segment is projected to grow at the highest CAGR as the world is changing to online shopping. There is also rising trend of self-medication among adults which, has led to purchase of dermatology drugs and medicines through online channels without any prior prescriptions.
It is no secret that the internet has become a popular place to buy everything from clothes to groceries. Now, it seems that even medications are being added to the list of items that can be bought online. A recent study of the global dermatology drugs market found that the number of people buying dermatology drugs online has increased significantly in recent years. In fact, it is now the second most popular way to purchase these medications, behind only going to the doctor and getting a prescription. There are a number of reasons why this trend is occurring. One of the most significant is that it is simply more convenient to buy medications online.
Based on market segmentation by region, North America is leading the market share in the global dermatology drugs market. There are a number of reasons why the US and Canada are the major consumers of dermatology drugs. Firstly, the prevalence of skin conditions is higher in these countries than in any other region of the world. According to a report by the World Health Organization, over 80% of the population in the US and Canada suffer from some form of skin disease. Secondly, the standard of living in these countries is generally higher than in other parts of the world, which means that people have more disposable income to spend on items like dermatology treatment drugs or medications. In addition, the healthcare systems in North America dermatology drugs market are generally more developed and able to provide better access to dermatology treatments. Finally, the marketing and advertising of dermatology drugs is much more sophisticated in the US and Canada than it is in other parts of the world. Pharmaceutical companies invest heavily in marketing their products in these countries, which drives up demand for their products.
By Drug Type
By Route of Administration
By Therapeutic Application
By Distribution Channel
|Market Size Value in 2022||US$ 18.42 Billion|
|Expected Revenue in 2031||US$ 45.35 Billion|
|Unit||Value (USD Bn)|
|Segments covered||By Drug Type, By Formulation, By Route of Administration, By Therapeutic Application, By Distribution Channel, By Region|
|Key Companies||Amgen Inc, Bausch Health Companies Inc., Botanix Pharmaceuticals, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, LEO Pharma A/S, Merck KGaA, Mylan N.V., Novartis AG, Pfizer Inc., Other Prominent Players|
|Customization Scope||Get your customized report as per your preference. Ask for customization|
The market size of the global dermatology drugs was valued at US$ 18.42 Bn in 2022.
The market is registered to grow at a CAGR of 11.0% during 2023-2030.
Rising demand for skin- and hair-related formulations among people and rise in skin related diseases among people are the factors triggering growth of the dermatology drugs market.
Rising prices of dermatology drugs and shortage of workforce/physicians and dermatologists are the factors restraining market growth.
Surge in new drug approvals is current trend in the market.
The various segmentations considered to analyze the global dermatology drugs are based on drug type, formulation, route of administration, therapeutic application, distribution channel, and country.
Negative impact of climate change on skin will shift people towards dermatology drugs as a remedy for skin issues
Branded Prescription Drugs segment dominated the global dermatology drugs in 2022.
Offline distribution channel held the highest segmental share in 2022.
North America dominated the global dermatology drugs market in 2022.
Novartis AG, Pfizer Inc., Johnson & Johnson, and Amgen Inc are the key players analyzed in the global dermatology drugs market.
The pandemic had a negative impact on the global dermatology drugs market, with a 4.0% drop in Y-O-Y growth of 2019-2020.
LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.SPEAK TO AN ANALYST